Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/2f8f4cef-5c73-4177-9bd3-b3034f599d39/

ELOX

Eloxx Pharmaceuticals, Inc. Common Stock
Chart
11.81 USD
Latest Week 2026-07-10
Snapshot 2026-07-12 · 0.1w · Fresh
0.79
OS Score
63.0%
Value
62.0%
Quality
65.0%
Momentum
1/9
F-Score
0.625
QV
Strategy Eligibility
1 of 23 passing
OS Composite
Trending Value
Quality × Value
QV 0.625
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
63.0%ile
FCF Yield
0.000
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
37.00000000
/100 — 1=cheapest
VC2 (Trending Value)
38.00000000
/100
VC3 (Buyback)
38.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
62.0%ile
ROE
0.790
ROA
-0.705
D/E
-2.12
Current
0.48
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.419
lower=better
Accruals
0.039
lower=better
5yr Consist
No
ROE of 79% is exceptional. Conservative balance sheet with D/E of -2.12. F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
65.0%ile
Max DD 12M
-15.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.79
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
77.8%
Sector Quality %ile
75.4%
Sector Avg OS
64.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 95.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 89.0% 93.0% 94.0%
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 90.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 90.0% 91.0% 98.0%
NUTX Nutex Health Inc 99.0% 90.0% 98.0% 86.0%
TBPH Theravance Biopharma Inc 99.0% 90.0% 99.0% 88.0%
INVA Innoviva Inc 98.0% 94.0% 94.0% 75.0%
CGEN Compugen 98.0% 89.0% 96.0% 85.0%
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
12.7% avg (2 factors)
Quality
C
48.9% avg (5 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends5 snapshots
Factor Persistence5 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.790—1
Value %ile0.630—0
Quality %ile0.620—0
Momentum %ile0.650—0
F-Score1.000—5
Confidence0.386—5
Volatility—0
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
FCF Yield
0.0%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
79.0%
Return on Assets
-70.5%
Debt / Equity
-2.12
Current Ratio
0.48
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.039
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.419
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
37
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
38
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
38
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity